Literature DB >> 8360125

Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.

A E Asuquo1, L J Piddock.   

Abstract

The accumulation of fifteen quinolone antimicrobial agents (nalidixic acid, eight mono-fluorinated agents, three di-fluorinated agents and three tri-fluorinated agents) by Escherichia coli KL16, Staphylococcus aureus NCTC 8532 and Pseudomonas aeruginosa NCTC 10662 was studied. The concentration of quinolones accumulated varied with the quinolone and the bacterial species, and was not affected by the number of fluorine atoms on the quinolone nucleus. There was also no direct relationship between the hydrophobicity or the molecular size of each drug and accumulation or activity. The killing of the three strains by the fifteen quinolones at a concentration of 10 mg/L was determined in broth and phosphate buffer to mimic the conditions of the accumulation assay. The bactericidal activity varied with the agent and the strain, and usually reflected the in-vitro activity of the drug. Despite most agents causing a decrease in the viable count of the three strains there was no detectable effect on the pattern of accumulation of the quinolones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360125     DOI: 10.1093/jac/31.6.865

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

1.  Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges.

Authors:  M V Moretti; S Pauluzzi; M Cesana
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium.

Authors:  L J Piddock; D G White; K Gensberg; L Pumbwe; D J Griggs
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Effect of fluorine substitution on the interaction of lipophilic ions with the plasma membrane of mammalian cells.

Authors:  M Kürschner; K Nielsen; J R von Langen; W A Schenk; U Zimmermann; V L Sukhorukov
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

Review 4.  Defining new chemical space for drug penetration into Gram-negative bacteria.

Authors:  Shibin Zhao; Justyna W Adamiak; Vincent Bonifay; Jitender Mehla; Helen I Zgurskaya; Derek S Tan
Journal:  Nat Chem Biol       Date:  2020-11-16       Impact factor: 15.040

Review 5.  Permeability barriers of Gram-negative pathogens.

Authors:  Helen I Zgurskaya; Valentin V Rybenkov
Journal:  Ann N Y Acad Sci       Date:  2019-06-04       Impact factor: 5.691

6.  Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.

Authors:  P M Furneri; M Fresta; G Puglisi; G Tempera
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Authors:  S Raherison; P Gonzalez; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.

Authors:  Hidemasa Nakaminami; Norihisa Noguchi; Masanori Sasatsu
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

9.  Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.

Authors:  T Takenouchi; F Tabata; Y Iwata; H Hanzawa; M Sugawara; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Tissue distribution of enrofloxacin in African clawed frogs (Xenopus laevis) after intramuscular and subcutaneous administration.

Authors:  Stephen Felt; Mark G Papich; Antwain Howard; Tyler Long; Gabriel McKeon; Stéphanie Torreilles; Sherril Green
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-03       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.